Swiss drugmaker Roche said on Monday it had expanded its artificial intelligence computing capacity with more than 2,100 Nvidia chips to support drug and diagnostics development.
Roche said the additional hardware âwould speed â up â work across its research and development operations, including âmodelling, data analysis and clinical trial processes.
The drugmaker said âit had deployed 2,176 Nvidia Blackwell graphics processing units (GPUs) across sites in the U.S. âand Europe, giving it the â largest GPU âfootprint in the industry.
The build-up, âwhich âbegan in 2023, is part of â a wider collaboration with Nvidia by âRoche, which has been increasing investment âin AI tools as large pharmaceutical groups compete to cut development timelines and reduce costs.
"In healthcare, time is the most critical variable," Chief Digital and Technology Officer âWafaa Mamilli said.
Drugmakers have announced a slew of deals for tools to âunleash the âpromise of â artificial intelligence, seen as the biggest technological breakthrough since the internet.
Agentic AI, which requires little human âintervention, could increase clinical development productivity by about 35% to 45% over the next five years, consultancy McKinsey said last year.
Roche said the additional hardware âwould speed â up â work across its research and development operations, including âmodelling, data analysis and clinical trial processes.
The drugmaker said âit had deployed 2,176 Nvidia Blackwell graphics processing units (GPUs) across sites in the U.S. âand Europe, giving it the â largest GPU âfootprint in the industry.
The build-up, âwhich âbegan in 2023, is part of â a wider collaboration with Nvidia by âRoche, which has been increasing investment âin AI tools as large pharmaceutical groups compete to cut development timelines and reduce costs.
"In healthcare, time is the most critical variable," Chief Digital and Technology Officer âWafaa Mamilli said.
Drugmakers have announced a slew of deals for tools to âunleash the âpromise of â artificial intelligence, seen as the biggest technological breakthrough since the internet.
Agentic AI, which requires little human âintervention, could increase clinical development productivity by about 35% to 45% over the next five years, consultancy McKinsey said last year.
Meridiano
